Reuters logo
BRIEF-Achieve Life Sciences entered into exclusive supply agreement with Sopharma AD
October 26, 2017 / 10:17 AM / a month ago

BRIEF-Achieve Life Sciences entered into exclusive supply agreement with Sopharma AD

Oct 26 (Reuters) - Sopharma Ad

* Achieve Life Sciences -‍ co entered into exclusive supply agreement with Sopharma AD for manufacture of Cytisine API and finished tablets​

* Achieve Life Sciences Inc - ‍exclusive license agreement provides supply of Cytisine to co for up to 20 years​

* Achieve Life Sciences Inc - ‍sopharma agrees to produce CGMP-grade Cytisine for achieve’s use in development and commercialization of Cytisine​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below